logo
Bill Gates enters race to build mini-nuclear reactors in Britain

Bill Gates enters race to build mini-nuclear reactors in Britain

Yahoo16-04-2025

A company founded by Bill Gates has submitted a bid to build mini-nuclear reactors in Britain, dealing a potential blow to Rolls-Royce's hopes of dominating the domestic market.
Seattle-based TerraPower has written to the Government outlining its intention to submit its reactor design for regulatory approval.
The move kickstarts efforts by the US company to enter an increasingly competitive market to build small modular reactors (SMR), which are expected to play a key role in the UK's shift to cleaner energy.
The Microsoft billionaire's company has developed a reactor, called Natrium, that uses a molten sodium heat storage system that allows it to rapidly ramp up its power output at peak times. Natrium is the Latin word for sodium which has the chemical symbol Na.
Chris Levesque, TerraPower chief executive, said: 'I am incredibly excited to begin the process of licensing the Natrium technology in the UK.
'TerraPower is committed to deploying Natrium units globally and has been in active discussions in the UK for years. There is immense interest and opportunity for the United States and United Kingdom to cooperate on deploying advanced nuclear plants over the coming decade.'
TerraPower's bid for approval will pile further pressure on Rolls-Royce, which is vying to lead the country's development of mini-nuke technology.
The British engineering giant is already facing a battle to get its SMR project approved after ministers launched a competitive tender for the country's mini-nuke programme.
GE Hitachi, Holtec and Westinghouse have also been shortlisted alongside Rolls-Royce for the contract, with government body Great British Nuclear expected to make a final decision 'in the spring'.
Tufan Erginbilgiç, chief executive of Rolls-Royce, last month warned that Britain risked missing out in the race to develop nuclear power if ministers failed to close the process by the end of June.
While TerraPower is not involved in the competition for the UK's SMR contract, the potential entrant of a new deep-pocketed rival into the market will pose a fresh challenge to Rolls-Royce's plans.
Mr Gates co-founded TerraPower in 2006 with the aim of building reactors that will dramatically bring down the cost of nuclear power.
The company broke ground on its first site in Wyoming last year, with construction expected to be completed in five years.
TerraPower plans to use its US regulatory approvals on this maiden site as the basis of its application in the UK, which will mark the first effort to deploy Natrium technology in a global market.
The company is submitting its bid for approval through the Generic Design Assessment, a voluntary process used by nuclear regulators to assess the safety, security and environmental impact of reactor designs.
Any application to build reactors at specific sites would be subject to a separate approval process.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution
Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution

Business Upturn

timean hour ago

  • Business Upturn

Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution

By Aditya Bhagchandani Published on June 19, 2025, 09:14 IST Marksans Pharma Limited announced today that its wholly owned UK-based subsidiary, Relonchem Limited, has received Marketing Authorization for Oxybutynin Hydrochloride 2.5mg/5ml Oral Solution from the UK's Medicines & Healthcare Products Regulatory Agency (MHRA). The product, used primarily for treating overactive bladder and urinary incontinence, expands Marksans' offering in the urology therapeutic segment and strengthens its European portfolio. The company, headquartered in Mumbai, manufactures and markets generic pharmaceutical formulations globally, with facilities in India, the US, and the UK—approved by regulatory bodies including the USFDA, UKMHRA, and Australia's TGA. 'This approval further reinforces our commitment to expanding our presence in regulated markets through high-quality generic products,' the company said in a press release. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Microsoft Plans to Cut Thousands More Employees
Microsoft Plans to Cut Thousands More Employees

Wall Street Journal

time3 hours ago

  • Wall Street Journal

Microsoft Plans to Cut Thousands More Employees

Microsoft MSFT 0.46%increase; green up pointing triangle is planning to lay off several thousand employees in the next few weeks, looking to thin out its ranks while continuing its costly push into artificial intelligence. The reduction of thousands of jobs will affect its sales department and other teams, people familiar with the matter said. The number of cuts isn't yet final, and they are planned for around the beginning of Microsoft's new fiscal year, which starts in July, they said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store